The global precision nutrition market is valued at USD 6.09 billion in 2024 and is expected to grow to USD 12.89 billion by 2029, registering a robust CAGR of 16.2% during the forecast period. This growth is driven by advancements in genomics, multi-omics technologies, and AI-powered analytics, which enable highly personalized dietary recommendations. Rising consumer demand for individualized health solutions, fueled by greater awareness of the link between diet and disease prevention, is a major factor contributing to this market expansion.
In addition, the increasing prevalence of lifestyle-related disorders and a broader shift toward preventive healthcare approaches have significantly boosted the adoption of precision nutrition. Supportive government policies, growing investment in research and development, and the expansion of wellness initiatives by healthcare providers are also accelerating market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2370137
Genomics and Multi-Omics Lead Among Service Types
Within the service type segment, the genomics and multi-omics category holds the largest market share. Technologies such as genomics, proteomics, metabolomics, and microbiomics are key enablers of personalized dietary strategies, offering deep insights into genetic predispositions, metabolic activities, and gut microbiota interactions. These innovations enhance the effectiveness of nutrition interventions across healthcare, wellness, and food sectors. As personalized wellness continues to gain traction among consumers, genomics and multi-omics remain central to the evolution of precision nutrition.
Vitamins Dominate the Supplement Segment.
In the supplement segment, vitamins represent the largest market share through 2024–2029. This is largely due to their role in addressing individual nutrient deficiencies and supporting overall health. Personalized vitamin supplements have gained widespread popularity as they align with genetic profiles, lifestyle factors, and specific health conditions. Consumers are increasingly seeking customized solutions to boost immunity, energy, and metabolic health. Enhanced diagnostic tools, particularly those leveraging multi-omics technologies, are enabling more accurate and tailored vitamin recommendations, reinforcing their market dominance.
Europe Holds a Prominent Market Share by Region
Regionally, Europe commands a significant share of the global precision nutrition market. This is attributed to the region’s advanced healthcare infrastructure, strong consumer awareness of personalized health solutions, and substantial government funding for genomics and nutritional research. Europe is home to leading biotech firms and research institutions that are spearheading innovations such as DNA-based diet planning and microbiome analysis. The growing demand for tailored wellness programs and the rising incidence of chronic diseases are further accelerating the adoption of precision nutrition across the continent. Key growth markets include Germany, the UK, and France, all of which are expected to reinforce Europe’s leadership in this space.
Leading Precision Nutrition Companies:
The report profiles key players such as Viome Life Sciences, Inc. (US), Prenetics Global Limited (China), ZOE Limited (UK), myDNA Life Australia Pty Ltd. (Australia), 23andMe, Inc. (US), DayTwo Inc. (US), Nutrigenomix (Canada), Genesis Healthcare Co. (Japan), AMILI (Singapore), and SelfDecode (US).
